Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

TEXAS NEUROFIBROMATOSIS FOUNDATION

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 17, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
f55e45e4-fa3c-49fc-a65e-edee2f8a2449
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Medical research issues and Neurofibromatosis provisions, as follows: H.R.4016/s.2572, Department of Defense Appropriations Act, FY2026 H.R.5304/s.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026

Literal federal measure citations: H.R.4016, s.2572, H.R.5304, s.2587

DEF · Defense

H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026, Medical research issues and Neurofibromatosis provisions

Literal federal measure citations: H.R.4016, S.2572

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.